Sign Up for Our E-Newsletter

Ask the Expert

Into the Weeds: What You Need to Know About Medical Marijuana & CRC Part III

Posted on May 18, 2016

into the weeds - Blog Graphic

While the use of marijuana has been around for thousands of years, it has only become legal in 24 states and the District of Columbia within recent history. As more states continue to approve marijuana for medical purposes, it’s important to separate the myths from the facts surrounding this drug.

This blog is the third in this series. Read Part I and Part II.

Research Studies

Cannabis research policies vary across the world. For example, Canada and the Netherlands have government-run programs in which specialized companies supply quality-controlled herbal cannabis. The Czech Republic, Israel, Canada and the Netherlands have government-sponsored research programs. 

Read more

Into the Weeds: What You Need to Know About Medical Marijuana & CRC – Part II

Posted on May 17, 2016

into the weeds - Blog Graphic

While the use of marijuana has been around for thousands of years, it has only become legal in 24 states and the District of Columbia within recent history. As more states continue to approve marijuana for medical purposes, it’s important to separate the myths from the facts surrounding this drug.

This blog is the second in this series. Read Part I here.

Cannabis: Does it Cure Cancer?

If there is one common theme in all of the literature and scientific papers, it is that cannabis and cannabinoids enhance the benefits of conventional treatment for side effect management.

Read more

What is Charity Care?

Posted on March 7, 2016

14445634744_3d2d72c990_o

Medical debt is a growing problem in America. I see it every day in my work as a certified patient navigator and patient advocate here at the Colon Cancer Alliance. Almost 60% of calls to our Helpline have to do with financial need.

As treatments get more specialized and personalized, costs will continue to rise. This financial toxicity is just as dangerous to patients as chemotherapy side effects like neuropathy, rashes, etc. Medical debt is now the leading cause of bankruptcy in America.

One solution to this problem is charity care. Read more

New Study: Recurrence, Proton Pump Inhibitors & Capecitabine

Posted on January 12, 2016

capecitabine-tablets-842250

In a recent observational study published in the journal Clinical Colorectal Cancer, authors found that in patients with early stage colorectal cancer who use proton pump inhibitors (PPIs) and are on monotherapy with capecitabine there is an increase in recurrence (a decrease in recurrence-free survival) but not a difference in overall survival. 

The use of proton pump inhibitors (PPIs) are a common treatment for acid reflux and include drugs like Prilosec, Zantac and Prevacid.

This new study echoes a previous finding on patients on monotherapy with capecitabine and who take PPIs for stomach cancer.

Axel Grothey, MD from Mayo Clinic, recommends that until further studies are done, patients who are on PPIs should receive infusional 5FU and not capecitabine, if possible. It is important to talk to your doctor before you make any medical decisions.

Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have additional questions about screening or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help! 

Ask the Expert: What Keytruda’s FDA Status Could Mean For You

Posted on December 1, 2015

Keytruda

Last month, we updated you when the FDA gave pembrolizumab (Keytruda) breakthrough status, which will speed up the development and review for the drug’s FDA approval. Now, stage IV survivor and Colon Cancer Alliance Medical Advisor and Patient Advocate Dr. Laura Porter gives us more insight into why this new drug and its breakthrough status is an important step forward. 

Read more

css.php